CD34 and dermatofibrosarcoma protuberans: Immunohistochemistry is critical for distinguishing dermatofibromas (Factor XIIIa-positive and CD34-negative) from dermatofibrosarcoma protuberans (CD34-positive and Factor XIIIa-negative) [21].